Watchlist Price Alert

Grace Therapeutics Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

2.94

-0.02 (-0.68%)

At close: Jun 26, 2025, 3:56 PM

2.96

0.68%

After-hours: Jun 26, 2025, 05:52 PM EDT

Grace Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Net Income	-9.57M	-12.85M	-42.43M	-9.82M	-19.68M	-25.51M	-39.37M	-16.65M
Depreciation & Amortization	7K	11K	124K	n/a	924K	2.32M	2.33M	2.07M
Stock-Based Compensation	730K	913K	1.81M	1.34M	1.17M	1.95M	777K	719.37K
Other Working Capital	n/a	-1.36M	483K	-2.77M	-6M	-3.8M	6.81M	3.2M
Other Non-Cash Items	n/a	2.71M	33.94M	-5.32M	9.21M	1.51M	5.28M	1.39M
Deferred Income Tax	-3.2M	-1.83M	-9.54M	-648K	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-1.28M	181K	-2.79M	-5.95M	-3.22M	6.19M	2.77M
Operating Cash Flow	-14.9M	-12.33M	-15.91M	-17.23M	-14.32M	-22.95M	-24.79M	-9.69M
Capital Expenditures	n/a	-22K	-17K	n/a	-69K	-319K	-534K	-352.33K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-15K	-6.55M	-5.01M	-34.93M	-9.81M	-1.92M	-18.85M	-20.13K
Sales Maturities Of Investments	15K	6.57M	18.18M	31.41M	21K	10.38M	9.94M	n/a
Other Investing Acitivies	n/a	111K	n/a	n/a	n/a	n/a	n/a	54.2K
Investing Cash Flow	n/a	104K	13.15M	-3.52M	-9.86M	8.14M	-9.44M	-318.26K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-1.56M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-30.97K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	21K	n/a	n/a	158K	7.76M	798K	295.03K
Financial Cash Flow	14.03M	7.36M	304K	n/a	59.49M	13.18M	45.69M	8.83M
Net Cash Flow	-872K	-4.87M	-2.46M	-20.6M	36.7M	-2.63M	10.45M	-1.2M
Free Cash Flow	-14.9M	-12.36M	-15.93M	-17.23M	-14.39M	-23.27M	-25.32M	-10.05M